Advertisement
Loading...

Ultragenyx Pharmaceutical Inc.

RARE•NASDAQ
Healthcare
Biotechnology
$25.00
$-0.80(-3.10%)
U.S. Market opens in 39h 26m

Ultragenyx Pharmaceutical Inc. (RARE) Stock Overview

Explore Ultragenyx Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.5B
P/E Ratio-4.13
EPS (TTM)$-6.10
ROE15.67%
Fundamental Analysis

AI Price Forecasts

1 Month$23.22
3 Months$14.15
1 Year Target$14.15

RARE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ultragenyx Pharmaceutical Inc. (RARE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.13 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.10%
5-Day Change
-4.03%
1-Month Change
-0.71%
3-Month Change
21.83%
6-Month Change
-24.43%
Year-to-Date (YTD) Change
8.70%
1-Year Change
-28.24%
3-Year Change
-49.00%
5-Year Change
-77.33%
All-Time (Max) Change
-40.83%

Contact Information

https://www.ultragenyx.com
415 483 8800
60 Leveroni Court, Novato, CA, 94949

Company Facts

1,294 Employees
IPO DateJan 31, 2014
CountryUS
Actively Trading

Frequently Asked Questions